GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use

GE HealthCare Technologies Inc. (GEHC) recently announced FDA approval for Optison, its polyethylene glycol (PEG)-free ultrasound enhancing agent, for use in pediatric patients. This milestone expands the application of Optison to children of all ages, enabling clearer and more accurate echocardiogram imaging.As one of the only ultrasound agents in the United States without PEG, Optison offers a safer alternative for patients with PEG hypersensitivity. With a proven safety profile and decades of clinical us ...